Bird & Bird partners with an innovative NFT and blockchain-based project created to fund treatment of cancer patients

Bird & Bird lawyers from the Warsaw office provided pro bono legal assistance to the "Buy My Cancer" project created by the Alivia Cancer Foundation in Poland. The project is an innovative model allowing the foundation to raise money for charitable purposes via Non-Fungible Tokens (NFT). The money raised will fund the costly treatment of patients with malignant tumours, who remain under the care of the Alivia Cancer Foundation, and in particular will cover the cost of treatment methods that are not reimbursed in Poland.

The project is a joint collaboration of the Alivia Cancer Foundation, the Maria SkÅ‚odowska-Curie National Research Institute of Oncology in Gliwice and artist PaweÅ‚ SWANSKI. It is a combination of science, art, medicine and business in an effort to save patients’ lives. The project involves using pictures of real cancer cells that are transferred to works of art which are then turned into NFT which are proof of donation to the foundation. 

Bird & Bird's lawyers prepared the legal and tax concept of the fundraising, drafted a request to the Director of the National Fiscal Inquiry Office for an individual tax ruling, prepared the rules and regulations of the project, and performed a legal review of the information materials.

The following lawyers from our Warsaw office were involved in the pro bono work: Tomasz Zalewski, Bartlomiej Sikora, Mateusz Bednarski, Aleksandra Cywinska, and Michal Smiechowski.

Bid NFT and support

Read more: www.buymycancer.org 

News & Deals

More News & Deals
News Bird & Bird adds bench strength in Germany with two new partner hires

Dec 29 2025

Read More
Deal Bird & Bird advises the African Development Bank on €100 million financing to strengthen the cocoa sector in Ivory Coast

Dec 18 2025

Read More
Deal Bird & Bird advises ASX-listed Flight Centre Travel Group on its acquisition of Iglu

Dec 17 2025

Read More
Deal Bird & Bird advises Pathos Communications plc on its AIM IPO

Dec 17 2025

Read More
Deal Bird & Bird advises Orphalan on the acquisition of Orphelia Pharma

Dec 16 2025

Read More
Deal Bird & Bird ATMD advises SuperX on Strategic Investment in NVIDIA Solution Provider MicroInference

Dec 15 2025

Read More